Effect of Lipid Modification on Progression of Coronary Calcification
- 1 November 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Journal of the American Society of Nephrology
- Vol. 16 (11_suppl_2) , S115-S119
- https://doi.org/10.1681/asn.2005060664
Abstract
Holesterol, elevated triglycerides, elevated LDL cholesterol, and elevated total cholesterol) are important factors in the calcification process. The annual progression of CAC can be reduced from 25 to 30% to 0 to 6% with LDL cholesterol reduction caused by statins and possibly sevelamer. At treated LDL cholesterol levels somewhere below 100 mg/dl, several sources of data suggest the anatomic burden of CAD, including CAC, regresses. Additional supportive studies indicate that carotid intimal medial thickness and the volume of coronary atheroma also can be reduced by LDL cholesterol reduction in concert with elevation of HDL cholesterol. This article reviews the data in support of altering the natural history of CAC with lipid modification....Keywords
This publication has 19 references indexed in Scilit:
- Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2Circulation, 2004
- A comparison of HDL and LDL cholesterol for prevalent coronary calcificationInternational Journal of Cardiology, 2004
- The predictive power of low-density lipoprotein cholesterol for coronary calcificationInternational Journal of Cardiology, 2003
- Cardiovascular disease risk status in elderly persons with renal insufficiencyKidney International, 2002
- Influence of Lipid-Lowering Therapy on the Progression of Coronary Artery CalcificationCirculation, 2002
- Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patientsKidney International, 2002
- Effect of HMG-CoA Reductase Inhibitors on Coronary Artery Disease as Assessed by Electron-Beam Computed TomographyNew England Journal of Medicine, 1998
- Coronary Artery Calcification: Pathophysiology, Epidemiology, Imaging Methods, and Clinical ImplicationsCirculation, 1996
- Bone morphogenetic protein expression in human atherosclerotic lesions.Journal of Clinical Investigation, 1993
- Noninvasive definition of anatomic coronary artery disease by ultrafast computed tomographic scanning: A quantitative pathologic comparison studyJournal of the American College of Cardiology, 1992